Evoke Pharma, Inc.

Q2 2022 13F Holders

Symbol
EVOK
CUSIP
30049G203
Type
Equity
Class
COM NEW
Num filings
14
Total reported value, excl. options
$228 k
Manager Report Date Value ($000) Shares Option Type